Freya Biosciences is moving a microbial immunotherapy for IVF implantation failure into mid-stage trials after promising results in healthy volunteers.

The Phase 2 study is testing Freya’s candidate, called FB301, in women with vaginal dysbiosis …

The trend of fewer companies letting employees go, which began in the fourth quarter of last year, has continued. However, more employees were on the chopping block in Q1 2026 than in Q1 2025, due mainly to one company’s cuts.

Abridge is partnering with top medical journals to bring in research for doctors to refer to during visits, pitting it against medical search giant OpenEvidence as more companies push to become all-in-one platforms for doctors.

…​ ​Read More